Cargando…

Whole-Brain Atrophy Rate in Idiopathic Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy

In multiple system atrophy (MSA) and progressive supranuclear palsy (PSP), the absence of surrogate endpoints makes clinical trials long and expensive. We aim to determine annualized whole-brain atrophy rates (a-WBAR) in idiopathic Parkinson's disease (IPD), MSA, and PSP. Ten healthy controls,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guevara, C., Bulatova, K., Barker, G. J., Gonzalez, G., Crossley, N., Kempton, M. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848442/ https://www.ncbi.nlm.nih.gov/pubmed/27190673 http://dx.doi.org/10.1155/2016/9631041

Ejemplares similares

Whole-Brain Atrophy Differences between Progressive Supranuclear Palsy and Idiopathic Parkinson’s Disease
por: Guevara, Carlos, et al.
Publicado: (2016)

Identification of multiple system atrophy mimicking Parkinson’s disease or progressive supranuclear palsy
por: Miki, Yasuo, et al.
Publicado: (2021)

Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease
por: Kass-Iliyya, Lewis, et al.
Publicado: (2015)

Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy
por: Brown, Jesse A., et al.
Publicado: (2017)

Force Control Deficits in Individuals with Parkinson’s Disease, Multiple Systems Atrophy, and Progressive Supranuclear Palsy
por: Neely, Kristina A., et al.
Publicado: (2013)

Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy
por: Worker, Amanda, et al.
Publicado: (2014)

Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy
por: Mitchell, Trina, et al.
Publicado: (2022)

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE
por: Payan, Christine A. M., et al.
Publicado: (2011)

Clinical Profile of Cognitive Decline in Patients with Parkinson's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Sulena,, et al.
Publicado: (2017)

Serum GDF-15 Levels in Patients with Parkinson’s Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy
por: Miyaue, Noriyuki, et al.
Publicado: (2023)

Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
por: Müller, Sebastian Johannes, et al.
Publicado: (2023)

Clinical Features and Disability Milestones in Multiple System Atrophy and Progressive Supranuclear Palsy
por: Lee, Sang-Wook, et al.
Publicado: (2012)

Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
por: Rogozinski, Sophia, et al.
Publicado: (2022)

The Use of Cerebellar Hypoperfusion Assessment in the Differential Diagnosis of Multiple System Atrophy with Parkinsonism and Progressive Supranuclear Palsy-Parkinsonism Predominant
por: Madetko-Alster, Natalia, et al.
Publicado: (2022)

Diffusion Tensor Imaging of Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy: A Tract-Based Spatial Statistics Study
por: Worker, Amanda, et al.
Publicado: (2014)

A new MRI rating scale for progressive supranuclear palsy and multiple system atrophy: validity and reliability
por: Rolland, Yan, et al.
Publicado: (2011)

Retrospective Diagnosis of Parkinsonian Syndromes Using Whole-Brain Atrophy Rates
por: Guevara, Carlos, et al.
Publicado: (2017)

Speech acoustic indices for differential diagnosis between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy
por: Daoudi, Khalid, et al.
Publicado: (2022)

Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy
por: Hu, Wen-Zheng, et al.
Publicado: (2023)

Clinical outcomes and cognitive impairments between progressive supranuclear palsy and multiple system atrophy
por: Jia, Peifei, et al.
Publicado: (2022)

Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
por: Bougea, Anastasia
Publicado: (2023)

The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom
por: McCrone, Paul, et al.
Publicado: (2011)

Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning
por: Scotton, William J, et al.
Publicado: (2023)

Fixel-Based Analysis of White Matter Degeneration in Patients With Progressive Supranuclear Palsy or Multiple System Atrophy, as Compared to Parkinson's Disease
por: Nguyen, Thanh-Thao, et al.
Publicado: (2021)

Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy
por: Sakuramoto, Hirotaka, et al.
Publicado: (2019)

Correction to: Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning
Publicado: (2023)

Atrophy in midbrain & cerebral/cerebellar pedunculi is characteristic for progressive supranuclear palsy – A double-validation whole-brain meta-analysis
por: Albrecht, Franziska, et al.
Publicado: (2019)

Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study
por: Wiblin, Louise, et al.
Publicado: (2019)

Multiscale Entropy of Resting-State Functional Magnetic Resonance Imaging Differentiates Progressive Supranuclear Palsy and Multiple System Atrophy
por: Kadota, Katsuhiko, et al.
Publicado: (2021)

The Assessment of Subregions in the Frontal Lobe May Be Feasible in the Differential Diagnosis of Progressive Supranuclear Palsy—Parkinsonism Predominant (PSP-P) and Multiple System Atrophy (MSA)
por: Alster, Piotr, et al.
Publicado: (2022)

The binaural masking level difference: cortical correlates persist despite severe brain stem atrophy in progressive supranuclear palsy
por: Hughes, Laura E., et al.
Publicado: (2014)

Thalamic and cerebellar hypoperfusion in single photon emission computed tomography may differentiate multiple system atrophy and progressive supranuclear palsy
por: Alster, Piotr, et al.
Publicado: (2019)

Diagnostic Accuracy of Magnetic Resonance Imaging Measures of Brain Atrophy Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Degeneration
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Parkinson disease and progressive supranuclear palsy: protein expression in skin
por: Rodríguez‐Leyva, Ildefonso, et al.
Publicado: (2016)

Temporal Progression Patterns of Brain Atrophy in Corticobasal Syndrome and Progressive Supranuclear Palsy Revealed by Subtype and Stage Inference (SuStaIn)
por: Saito, Yuya, et al.
Publicado: (2022)

Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease()
por: Lipp, Axel, et al.
Publicado: (2013)

The Role of the Evans Index and the Maximal Width of the Frontal Horns of the Lateral Ventricles in the Diagnostic Imaging of Progressive Supranuclear Palsy and Multiple-System Atrophy
por: Kutyłowski, Michał, et al.
Publicado: (2023)

Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy
por: Foley, Jennifer A., et al.
Publicado: (2018)

Utility of the Midbrain Tegmentum Diameter in the Differential Diagnosis of Progressive Supranuclear Palsy from Idiopathic Parkinson's Disease
por: Kim, Yool-Hee, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_84gm8bkjh5v3b6sni7m706rhql